Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Chayka, Mariya"'
Human gestational N‐methyl‐d‐aspartate receptor autoantibodies impair neonatal murine brain function
Autor:
Jurek, Betty, Chayka, Mariya, Kreye, Jakob, Lang, Katharina, Kraus, Larissa, Fidzinski, Pawel, Kornau, Hans���Christian, Dao, Le���Minh, Wenke, Nina K., Long, Melissa, Rivalan, Marion, Winter, York, Leubner, Jonas, Herken, Julia, Mayer, Simone, Mueller, Susanne, Boehm���Sturm, Philipp, Dirnagl, Ulrich, Schmitz, Dietmar, K��lch, Michael, Pr��ss, Harald
Objective: Maternal autoantibodies are a risk factor for impaired brain development in offspring. Antibodies (ABs) against the NR1 (GluN1) subunit of the N-methyl-d-aspartate receptor (NMDAR) are among the most frequently diagnosed anti-neuronal surf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5bba987205cbac22aba59e377575bd9d
https://refubium.fu-berlin.de/handle/fub188/33356
https://refubium.fu-berlin.de/handle/fub188/33356
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Jurek B; Department of Neurology and Experimental Neurology, Charité-Universitätsmedizin Berlin, Berlin, Germany.; German Center for Neurodegenerative Diseases (DZNE) Berlin, Berlin, Germany., Chayka M; Department of Neurology and Experimental Neurology, Charité-Universitätsmedizin Berlin, Berlin, Germany.; German Center for Neurodegenerative Diseases (DZNE) Berlin, Berlin, Germany., Kreye J; Department of Neurology and Experimental Neurology, Charité-Universitätsmedizin Berlin, Berlin, Germany.; German Center for Neurodegenerative Diseases (DZNE) Berlin, Berlin, Germany., Lang K; Department of Neurology and Experimental Neurology, Charité-Universitätsmedizin Berlin, Berlin, Germany.; German Center for Neurodegenerative Diseases (DZNE) Berlin, Berlin, Germany., Kraus L; Department of Neurology and Experimental Neurology, Charité-Universitätsmedizin Berlin, Berlin, Germany.; Clinical and Experimental Epileptology, Charité-Universitätsmedizin Berlin, Berlin, Germany.; Berlin Institute of Health, Berlin, Germany., Fidzinski P; Department of Neurology and Experimental Neurology, Charité-Universitätsmedizin Berlin, Berlin, Germany.; Clinical and Experimental Epileptology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Kornau HC; German Center for Neurodegenerative Diseases (DZNE) Berlin, Berlin, Germany.; Neuroscience Research Center, Charité-Universitätsmedizin Berlin, Berlin, Germany., Dao LM; Department of Neurology and Experimental Neurology, Charité-Universitätsmedizin Berlin, Berlin, Germany.; German Center for Neurodegenerative Diseases (DZNE) Berlin, Berlin, Germany., Wenke NK; German Center for Neurodegenerative Diseases (DZNE) Berlin, Berlin, Germany., Long M; Neurocure Cluster of Excellence, Animal Outcome Core Facility, Charité-Universitätsmedizin Berlin, Berlin, Germany., Rivalan M; Neurocure Cluster of Excellence, Animal Outcome Core Facility, Charité-Universitätsmedizin Berlin, Berlin, Germany., Winter Y; Neurocure Cluster of Excellence, Animal Outcome Core Facility, Charité-Universitätsmedizin Berlin, Berlin, Germany., Leubner J; Department of Neurology and Experimental Neurology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Herken J; Department of Neurology and Experimental Neurology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Mayer S; Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research and Department of Neurology, University of California, San Francisco, San Francisco, CA., Mueller S; Department of Neurology and Experimental Neurology, Charité-Universitätsmedizin Berlin, Berlin, Germany.; Neurocure Cluster of Excellence, Core Facility 7T Experimental MRIs, Charité-Universitätsmedizin Berlin, Berlin, Germany.; Center for Stroke Research, Charité-Universitätsmedizin Berlin, Berlin, Germany., Boehm-Sturm P; Department of Neurology and Experimental Neurology, Charité-Universitätsmedizin Berlin, Berlin, Germany.; Neurocure Cluster of Excellence, Core Facility 7T Experimental MRIs, Charité-Universitätsmedizin Berlin, Berlin, Germany.; Center for Stroke Research, Charité-Universitätsmedizin Berlin, Berlin, Germany., Dirnagl U; Department of Neurology and Experimental Neurology, Charité-Universitätsmedizin Berlin, Berlin, Germany.; German Center for Neurodegenerative Diseases (DZNE) Berlin, Berlin, Germany.; Center for Stroke Research, Charité-Universitätsmedizin Berlin, Berlin, Germany., Schmitz D; German Center for Neurodegenerative Diseases (DZNE) Berlin, Berlin, Germany.; Neuroscience Research Center, Charité-Universitätsmedizin Berlin, Berlin, Germany.; Einstein Center for Neurosciences, Berlin, Germany., Kölch M; Department for Child and Adolescent Psychiatry, Neurology, Psychosomatics, and Psychotherapy, Universitätsmedizin Rostock, Rostock, Germany., Prüss H; Department of Neurology and Experimental Neurology, Charité-Universitätsmedizin Berlin, Berlin, Germany.; German Center for Neurodegenerative Diseases (DZNE) Berlin, Berlin, Germany.; Department of Neurology, Center for Autoimmune Encephalitis and Paraneoplastic Neurological Syndromes, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Publikováno v:
Annals of neurology [Ann Neurol] 2019 Nov; Vol. 86 (5), pp. 656-670. Date of Electronic Publication: 2019 Sep 18.